SCHEMBL7250332

SCHEMBL7250332

CC(C)(C)[Si](OCC(=O)c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 3/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPK1 P28482 2/20 0.41
MEN1 O00255 2/20 0.41
CYP3A4 P08684 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ALOX15 P16050 1/20 0.41
CES1 P23141 1/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8354088 0.85 SMYD2 (0.36) NPC1TSHRSMN1; SMN2MAPTTDP1
Hydrochloric Acid SCHEMBL29015997 0.85 ALOX15 (0.41) L3MBTL1SMN1; SMN2MEN1CYP3A4KMT2A
SCHEMBL789538 0.85 ALOX15 (0.41) L3MBTL1SMN1; SMN2MEN1CYP3A4KMT2A
SCHEMBL3078638 0.84 L3MBTL1 (0.43) NPC1RAB9AL3MBTL1SMN1; SMN2HPGD
SCHEMBL7336991 0.83 SMYD2 (0.38) NPC1L3MBTL1SMN1; SMN2MAPTCYP3A4
SCHEMBL18787483 0.83 NPC1 (0.40) NPC1RAB9AL3MBTL1SMN1; SMN2MAPT
SCHEMBL10828679 0.82 SMYD2 (0.35) NPC1TSHRSMN1; SMN2MAPTTDP1
SCHEMBL4810133 0.82 SMYD2 (0.35) NPC1TSHRSMN1; SMN2HPGDMAPT
SCHEMBL25712841 0.82 KDM4E (0.39) L3MBTL1TSHRSMN1; SMN2MAPTCYP3A4
SCHEMBL7781357 0.81 POLB (0.39) L3MBTL1TSHRSMN1; SMN2HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030045727-A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups ASAHI KASEI KABUSHIKI KAISHA (JP) 2003-03-06 US disclosed
EP-1254885-A1 PROCESS FOR PREPARING OPTICALLY ACTIVE SECONDARY ALCOHOLS HAVING NITROGENOUS OR OXYGENIC FUNCTIONAL GROUPS Asahi Kasei Kabushiki Kaisha (JP) 2002-11-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045727-A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups ADH1A, ADH5, ADH1C NPC1 1483/4885RAB9A 2590/4885L3MBTL1 4559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.